Graeme Clark Collection
Permanent URI for this collection
Search Results
1 - 10 of 13
-
ItemCombined cochlear implant and speech processing hearing aid for implant users with a severe to profound hearing loss in the contralateral ear [Abstract]( 1994)The bimodal device was developed for cochlear implant users who simultaneously wear a hearing aid in the opposite ear having residual hearing of a severe to profound degree. The aim was to create a single device to provide both input signals in a more compatible manner and thus maximise use of the individual's total hearing capabilities. The acoustic component of the bimodal device is very flexible and can implement various speech processing strategies with speed, ease and precision. The Frequency Response Tailoring strategy utilises three filters to fit a frequency gain curve to within 1-2 dB of that desired. Modifications at discrete frequencies, ranges or slopes can be readily made. The Peak Sharpening or Spectral Enhancement strategy amplifies the formant peaks in speech for potential improvement of formant resolution and speech perception in the presence of background noise. The Resynthesis strategy presents specifically selected components of speech in selected combinations and includes the ability to transpose higher frequency information to lower frequency ranges for individuals with no aidable high frequency hearing levels. Different fits can be quickly and easily interchanged for comparison and evaluation and subsequent modifications indicated can be readily effected. Any combination of acoustic and implant speech processing strategy can be presented to optimise speech perception for the individual user.
-
ItemPitch perception for different modes of stimulation using the Cochlear multiple-electrode prosthesis( 1994)Abstract not available due to copyright.
-
ItemCochlear implants in children, adolescents, and prelinguistically deafened adults: speech perception( 1992)A group of 10 children, adolescents, and prelinguistically deafened adults were implanted with the 22-electrode cochlear implant (Cochlear Ply Ltd) at the University of Melbourne Cochlear Implant Clinic and have used the prosthesis for periods from 12 to 65 months. Postoperative performance on the majority of closed-set speech perception tests was significantly greater than chance, and significantly better than preoperative performance for all of the patients. Five of the children have achieved substantial scores on open-set speech tests using hearing without lipreading. Phoneme scores in monosyllabic words ranged from 30% to 72%; word scores in sentences ranged from 26% to 74%. Four of these 5 children were implanted during preadolescence (aged 5:5 to 10:2 years) and the fifth, who had a progressive loss, was implanted during adolescence (aged 14:8 years). The duration of profound deafness before implantation varied from 2 to 8 years. Improvements were also noted over postoperative data collection times for the younger children. The remaining 5 patients who did not demonstrate open-set recognition were implanted after a longer duration of profound deafness (aged 13:11to 20:1 years). The results are discussed with reference to variables that may affect implant performance, such as age at onset of loss, duration of profound loss, age at implantation, and duration of implantation. They are compared with results for similar groups of children using hearing aids and cochlear implants.
-
ItemPreliminary evaluation of a wearable multichannel electrotactile speech processor [Abstract]( 1988)Speech discrimination testing, using both open-and closed-set materials was carried out with four severely-to-profoundly hearing impaired adults. and seven normally hearing subjects, to assess performance of a wearable eight-channel electrotactile aid (Tickle Talker). The device consisted of a handset composed of nine electrodes, a stimulator-unit, and a speech processor and input microphone. Eight small electrodes were located over the digital nerve bundles on each side of the four fingers of one hand, and a larger common electrode was placed on the wrist. Subjects perceived eight separate channels of information, each corresponding to a stimulus on one side of one finger. The speech processor provided estimates of second formant frequency, fundamental frequency and amplitude of the speech waveform. These features were coded as electrode position, pulse rate and pulse width respectively. This processing strategy (FOF2AO) is similar to that used in an earlier model of the Cochlear Pty. Ltd. cochlear implant.
-
ItemPreliminary evaluation of a multichannel electrotactile speech processor( 1988)Abstract not available due to copyright.
-
ItemThe histopathology of the human temporal bone and auditory central nervous system following cochlear implantation in a patient: correlation with psychophysics and speech perception results( 1988)Cochlear implantation has become a recognised surgical procedure for the management of a profound-total hearing loss, especially in patients who have previously had hearing before going deaf (postlingual deafness). Nevertheless, it is important for progress in the field that patients who have had a cochlear implant, bequeath their temporal bones for research. This will then make it possible to further assess the safety of the procedure, and the factors that are important for its effectiveness. Biological safety has been assessed in a number of studies on animals, in particular, the biocompatibility of the materials used (1,2), the histopathological effects of long-term implantation on the cochlea (3, 4, 5, 6, 7, 8), and the effects of chronic electrical stimulation on the viability of spiral ganglion cells (9, 10, 11, 12). In studying the temporal bones of deceased cochlear implant patients it is possible to help establish that the animal experimental results are applicable to Man. Surgical trauma has been most frequently evaluated by inserting electrodes into cadaver temporal bones. It is important, however, to examine bones that have been previously implanted surgically to ensure that the cadaver findings are applicable to operations on patients. The effectiveness of cochlear implantation can be studied by correlating the histopathological findings, the dendrite and spiral ganglion cell densities, in particular, with the psychophysical and speech perception results. Other benefits also accrue, for example, establishing the accuracy of preoperative X-rays and electrical stimulation of the promontory in predicting cochlear pathology and spiral ganglion cell numbers. For the above reasons it has been especially interesting to examine both the temporal bones and central nervous system from one of our patients (patient 13) who participated in the initial clinical trial of the Cochlear Proprietary Limited (a member of the Nucleus group) multiple-electrode cochlear prosthesis, and who died due to a myocardial infarction following coronary bypass surgery.
-
ItemThe University of Melbourne/Nucleus cochlear prosthesis( 1988)This is a review of research to develop the University of Melbourne/Nucleus cochlear prosthesis for patients with a profound-total hearing loss. A more complete review can be obtained in Clark et al. A prototype receiver-stimulator and multiple-electrode array developed at the University of Melbourne was first implanted in a postlingually deaf adult patient with a profound-total hearing loss on 1 August 1978. A speech processing strategy which could help this patient understand running speech, especially when combined with lipreading was developed in 1978 following initial psychophysical studies. A prototype wearable speech processor was fabricated in 1979, that could provide significant help for the first two patients in understanding running speech when used in combination with lipreading compared with lipreading alone, and it also enabled them to understand some running speech when using electrical stimulation alone. An implantable receiver-stimulator and wearable speech processor embodying the principles of the prototype devices were then produced for clinical trial by the Australian biomedical firm, Nucleus Ltd, and its subsidiaries, Cochlear Pty Ltd and Cochlear Corporation. This cochlear implant was initially clinically trialled on six patients at The Royal Victorian Eye & Ear Hospital in 1982, and shown to give similar results to those obtained with the prototype device. In view of these findings a clinical trial was carried out for a Premarket Approval Application to the US Food and Drug Administration (FDA), and extended to a number of centres in the US, Canada, and West Germany. This clinical trial confirmed that patients could understand running speech when electrical stimulation was combined with lipreading, and that some patients could also understand running speech when using electrical stimulation alone. Today, more than 600 patients world-wide are using cochlear implants developed from the research described in this paper.
-
ItemPsychophysical studies relevant to the design of a digital electrotactile speech processor( 1987)Abstract not available due to copyright.
-
ItemAn acoustic model of a multiple-channel cochlear implant( 1984)Abstract not available due to copyright.
-
ItemSpeech processing studies using an acoustic model of a multiple-channel cochlear implant( 1984)Abstract not available due to copyright.